Business
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' PEA with NPV of $344 million and 137% IRR for Frances Creek Pharmaceutical Barium Project in BC - Video Available on Investmentpitch.com
Vancouver, British Columbia--(Newsfile Corp. - January 13, 2022) - Voyageur Pharmaceuticals (T...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' PEA with NPV of $344 million and 137% IRR for Frances Creek Pharmaceutical Barium Project in BC - Video Available on Investmentpitch.comVancouver, British Columbia--(Newsfile Corp. - January 13, 2022) - Voyageur Pharmaceuticals (TSXV: VM) (OTC Pink: VYYRF) has announced the results of its Preliminary Economic Assessment for the development of its Frances Creek pharmaceutical barium sulfate project. The Frances Creek project is a 100% owned pharmaceutical grade barium sulfate project located in British Columbia.For more information, please view the InvestmentPitch Media \"video\" which provides additional information about this news and the company, including video comments by Brent Willis, President and CEO of Voyageur Pharma, explaining the significance of this news. If this link is not enabled, please visit www.InvestmentPitch.com and enter \"Voyageur\" in the search box.Cannot view this video? Visit:http://www.investmentpitch.com/video/1_3o46vj5t/Voyageur-Pharmaceuticals-announces-PEA-with-NPV-of-344-million-and-137-IRR-for-Frances-Creek-Pharmaceutical-Barium-Project-in-BCVoyageur is focused on the development of barite and iodine Active Pharmaceutical Ingredients and high-performance cost-effective imaging contrast agents for the medical radiology marketplace. For those of you new to the company, contrast materials, which may be taken orally or rectally, are used to improve pictures of the inside of the body helping to distinguish or \"contrast\" selected areas of the body from surrounding tissue allowing the radiologist to distinguish normal from abnormal conditions.Working with its custom manufacturer, Alberta Veterinarian Laboratories, which owns and operates a brand new, multi-million dollar, state-of-the-art, Good Manufacturing Practice drug manufacturing facility in Calgary, Alberta, Canada, Voyageur is building a suite of barium products including Smooth X, Barium Sulfate 98% HDX, and a Barium Sulfate Drill Product.The PEA, prepared by SGS Geological Services, and a technical report relating to the PEA will be available on SEDAR within 45 days. The mineral resource estimate report was based on a database containing 57 drillholes and 3 channels totaling 3,106 metres.The estimate consisted of 214,800 tonnes in the Indicated category containing 75,600 tonnes...